Table 4 of
Querques, Mol Vis 2014; 20:575-592. Table 4 of
Querques, Mol Vis 2014; 20:575-592.
Table 4. Changes in mean measurements and in specific features in patients with Best vitelliform macular dystrophy progressing or not from pseudohypopyon stage to vitelliruptive stage.
| Pseudohypopyon to vitelliruptive (n=3) FU: 32.3±25.5 months | Study entry | Last visit | P value |
|---|---|---|---|
| BCVA (LogMAR) | 0.36±0.5 | 0.36±0.5 | - |
| Overall lesion area (mm2) | 5.32±2.9 | 5.16±3.3 | 0.6 |
| Hyperautofluorescent component of the lesion (mm2) | 2.41±1.8 | 0 | 0.01 |
| Hypoautofluorescent component of the lesion (mm2) | 2.91±2.7 | 5.16±3.3 | 0.01 |
| FAF fovea (n) | Hypo=3 | Hypo=3 | |
| EZ status fovea (n) | Disrupted=2/ Normal=1 | Disrupted=3 | |
| OCT reflectivity (n) | Mixed=3 | Hypo=3 | |
| Maximal OCT lesion thickness (μm) | 226.5±13.2 | 215.6±15.4 | 0.1 |
| Maximal OCT lesion width (μm) | 2110.5±895.9 | 2056.0±648.4 | 0.3 |
| OCT neurosensory retinal thickness fovea (μm) | 92.5±16.4 | 90.7 14.5 | 0.1 |
| CMT (μm) | 332.0±13.7 | 323.0±21.1 | 0.1 |
| Pseudohypopyon not progressing to vitelliruptive (n=3) FU: 45.3±28.9 months | Study entry | Last visit | P value |
| BCVA (LogMAR) | 0.22±0.11 | 0.26±0.1 | 0.1 |
| Overall lesion area (mm2) | 6.93±3.8 | 7.24±4.6 | 0.6 |
| Hyperautofluorescent component of the lesion (mm2) | 3.19±1.2 | 2.64±1.6 | 0.07 |
| Hypoautofluorescent component of the lesion (mm2) | 3.74±1.8 | 4.60±1.5 | 0.07 |
| FAF fovea (n) | Hypo=3 | Hypo=3 | - |
| EZ status fovea (n) | Disrupted=2/ Normal=1 | Disrupted=3 | |
| OCT reflectivity (n) | Mixed=3 | Mixed=3 | - |
| Maximal OCT lesion thickness (μm) | 321.4±71.8 | 293.5±88.4 | 0.2 |
| Maximal OCT lesion width (μm) | 2925.4±320.6 | 2815.0±331.8 | 0.1 |
| OCT neurosensory retinal thickness fovea (μm) | 94.6±15.3 | 87.5±14.8 | 0.1 |
| CMT (μm) | 450.4±41.4 | 423.0±60.8 | 0.1 |